注：如提及个股仅供参考，不代表投资建议。指数/基金短期涨跌幅及历史表现仅供分析参考，不 预示未来表现。市场观点随市场环境变化而变动，不构成任何投资建议或承诺。文中提及指数仅供参 考，不构成任何投资建议，也不构成对基金业绩的预测和保证。如需购买相关基金产品，请选择与风险 等级相匹配的产品。基金有风险，投资需谨慎。 中银国际指出，AI产业链景气趋势仍向好，下游需求旺盛，AI基础设施建设短期面临供应端存力 与电力短缺，资源紧缺带来存力与电力投资机会，算力特别是国产算力仍有广阔成长空间。在宽基指数 上，科创50、创业板指有望率先迎来修复，科技成长或最为受益。AI产业链有望成为春躁主线，流动 性预期及风险偏好修复将推动科技成长板块表现。 科创综指ETF国泰（589630）跟踪的是科创综指（000680），单日涨跌幅达20%，该指数覆盖科创 板几乎所有符合条件的上市公司，市值覆盖率接近100%。其成分股主要聚焦于生物医药等"硬科技"领 域，行业分布较为均衡，能够全面反映科创板市场的整体走势。科创综指采用全收益计算方式，将分红 收益计入其中，从而更好地展现长期投资回报价值。 （责任编辑：刘畅 ） 【免责声明】本文仅代表作者 ...

Group 1 - The global wafer foundry industry is expected to see a revenue growth of 22.1% year-on-year by 2025, driven by AI and electric vehicles, with shipment growth rates projected at 24% and 14% respectively for 2026 [1] - As semiconductor supply chain anxieties ease, customer inventory strategies are shifting towards healthier levels, with urgent orders expected to drive better-than-expected performance in the wafer foundry market in the second half of 2025 [1] - The demand for AI high-performance computing (HPC) is promoting the development of advanced packaging technologies, although CoWoS faces challenges such as capacity shortages, photomask size limitations, and high costs, leading some cloud service providers to shift towards Intel's EMIB technology [1] Group 2 - The electronic semiconductor industry may experience a comprehensive recovery in 2025, with an accelerated clearing and repair of the competitive landscape, leading to a sustained recovery in profit cycles and related company profits [1] - The Guotai Science and Technology Chip ETF (589100) tracks the Science and Technology Chip Index (000685), which has a daily fluctuation of 20%, focusing on semiconductor companies across the entire industry chain, including materials, equipment, design, manufacturing, and packaging testing [1]

每日经济新闻 （责任编辑：董萍萍 ） 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 中邮证券指出，医药生物板块2025年初至今震荡上行，短暂回调后性价比凸显，目前估值处于历史 中位，随着集采、院内反腐等负面因素出清，2026年有望表现突出。创新药领域，国内资产全球认可度 快速提升，MNC专利悬崖迫近，新品迭代需求强烈，美国药价政策频出利好国产新药出海；医保商保 协同发力下国产新药商业化前景优异。医疗器械板块部分企业25年三季度业绩迎来拐点，设备板块招投 标持续恢复，有望兑现至2026年业绩；耗材集采逐渐进入尾声，IVD板块在集采冲击下行业整合提速， 负面影响即将出清，整体看器械板块拐点初现，看好后续增长。 创业板医药ETF国泰（159377）跟踪的是创医药指数（399275），单日涨跌幅达20%，该指数聚焦 于创新生物医药领域，从市场中选取涉及生物技术、基因工程、新型疫苗及药物研发等业务的上市公司 证券 ...

财通证券表示，中国药企的BD交易在全球交易总额占比约30%，创新药研发呈现"多快好省"的特 点，成为海外药企产品引进的重要来源。国内药企从创新药项目需求方转变为提供方，BD收入已成为 拓展收入的重要来源。 （责任编辑：董萍萍 ） 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 注：如提及个股仅供参考，不代表投资建议。指数/基金短期涨跌幅及历史表现仅供分析参考，不 预示未来表现。市场观点随市场环境变化而变动，不构成任何投资建议或承诺。文中提及指数仅供参 考，不构成任何投资建议，也不构成对基金业绩的预测和保证。如需购买相关基金产品，请选择与风险 等级相匹配的产品。相关标的在市场波动、基本面变化等因素下，向下弹性或释放。基金有风险，投资 需谨慎。 每日经济新闻 科创创新药ETF国泰（589720）聚焦科创板创新药企业，跟踪汇聚30家代表性优质公司的上证科创 板创新药指数，以高成长biotech为主，产品20%涨 ...

Group 1: Characteristics of Interbank Certificate of Deposit Index Funds - The average yield of interbank certificate of deposit index funds is between that of money market funds and short-term bond funds, with a maximum drawdown of 0.18% and an annualized yield of 2.52% [1][8] - The underlying assets are primarily large-denomination deposits from banks, with the largest fund, "Huatai-PineBridge Interbank Certificate of Deposit Index 7-Day Holding," having 92% of its assets in interbank certificates [3] - Some funds may deviate from the norm, such as "Yimi Interbank Certificate of Deposit Index 7-Day Holding," which invested 19% in government bonds, although this is within the contractual limit of 20% for other investments [5] Group 2: Fund Performance and Management - As of 2024, the interbank certificate of deposit index has increased by 4.01% with a maximum drawdown of 0.06%, and only a few funds have outperformed this index [8][9] - The funds that have outperformed the index include "Chuangjin Hexin" and "Huatai-PineBridge," with respective yields of 4.17% and 4.07% [9] - The management fees for these funds are 0.2% annually plus a 0.05% custody fee, meaning a total of approximately 0.5% over two years [8] Group 3: Bond Fund Characteristics - The criteria for selecting bond funds include being a medium to long-term pure bond fund, with a maximum drawdown not exceeding 2% since 2021, and a yield exceeding 18% [10] - The "Medium to Long-Term Pure Bond Fund Index" has risen by 16.15% since 2021, with a maximum drawdown of 1.08% [10] - Notable funds that meet the criteria include "Penghua Fenglu" and "Southern Jinli," with respective yields of 29.80% and 32.47% [11] Group 4: Market Trends and Economic Indicators - The Federal Reserve's expectation for a rate cut in December has risen to 89.2%, influencing the recent rebounds in U.S. stocks, gold, and silver [22] - The potential appointment of Hassett as the new Fed Chair is seen as a positive for market liquidity, contributing to the strength of U.S. stocks and gold [25] - Concerns about market bubbles are highlighted, with current valuations being compared to historical highs, indicating a need for caution [25]

Group 1 - Google has launched its most powerful and energy-efficient accelerator, Ironwood, which is expected to enhance its AI infrastructure capabilities [1] - Meta plans to integrate Google's TPU into its data centers by 2027, with a potential deal size reaching several billion dollars [1] - The commercialization of AI software is accelerating, addressing concerns about the sustainability of AI investments [1] Group 2 - North American infrastructure/cloud service providers are increasingly collaborating with OpenAI, indicating a persistent demand for data center hardware [1] - The growth potential in the communication equipment sector is noteworthy and warrants close attention [1] - The Guotai AI ETF (159388) tracks the AI index (970070) and has seen a daily fluctuation of 20%, reflecting the performance of AI-related companies in the ChiNext market [1]

Core Insights - Public funds have distributed significant dividends this year, with over 3,300 funds distributing a total of approximately 215.52 billion yuan, surpassing last year's total in terms of quantity, frequency, and amount [1] - Bond funds have contributed over 150 billion yuan, maintaining their position as the main contributors, while equity products have also increased distributions due to favorable market conditions [1] - The A-share market experienced a decline on December 2, with major indices closing lower, and over 3,700 stocks falling [1] Fund News - On December 2, six new funds were launched, primarily bond and ETF-linked funds, while 40 funds distributed dividends, mostly from bond types [2] - The most significant dividend payout was from the Wanji New Opportunity Leading Enterprises Flexible Allocation Mixed Securities Investment Fund, distributing 1.8890 yuan per 10 shares [2] - A total of 27 public funds have lined up 34 new products for December issuance, with equity funds still dominating [2] - As the year-end approaches, expectations for a cross-year market rally are rising, with many institutions anticipating an influx of capital [2] Fund Performance - The best-performing fund on December 2 was the Guotou Ruijin Silver Futures (LOF) A, with a daily growth rate of 2.8362% [5] - In the stock fund category, the Tianhong Hang Seng Hong Kong Stock Connect High Dividend Low Volatility Index C led with a daily growth rate of 1.4659% [5] - The top bond fund was the Ping An Huijia Pure Bond Fund C, with a daily growth rate of 0.1078% [5] - The top mixed fund was the Hengsheng Qianhai Hong Kong Stock Connect Value Mixed C, achieving a daily growth rate of 1.1787% [5]

中邮证券指出，医药生物行业短暂回调后性价比凸显，随着集采、院内反腐等负面因素出清，2026 年有望表现突出。创新药方面，国内资产全球认可度快速提升，MNC专利悬崖迫近，新品迭代需求强 烈，美国药价政策频出，利好国产新药出海；医保商保协同发力，国产新药商业化前景优异。医疗器械 行业部分企业2025年三季度业绩迎来拐点，成长型企业整体增长稳定；设备板块招投标持续恢复，有望 兑现至2026年业绩；耗材集采逐渐进入尾声、IVD板块在集采冲击下行业整合提速，负面影响即将出 清，看好板块后续增长。 每日经济新闻 （责任编辑：董萍萍 ） 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 创业板医药ETF国泰（159377）跟踪的是创医药指数（399275），单日涨跌幅达20%，该指数从创 业板市场中选取涉及生物医药、医疗器械及相关服务业务的上市公司证券作为指数样本，以反映创业板 医药健康产业相关上市公司证券的整体表现。创 ...

Core Viewpoint - The electronic industry is experiencing a sustained recovery in demand, effective supply clearance, and rising prices for storage chips, with domestic production efforts exceeding expectations [1] Group 1: Industry Developments - Huawei has launched the Mate 80 series, featuring the HarmonyOS 6.0 operating system and the Kirin 9030 Pro chip, along with "Linglong Screen" display technology [1] - Alibaba has introduced the Quark AI glasses, which deeply integrate the Qianwen AI assistant and the Alibaba ecosystem, utilizing the Qualcomm AR1 flagship chip and the Hengxuan BES2800 chip to create an application ecosystem covering search, navigation, and payment scenarios [1] Group 2: Investment Opportunities - Structural opportunities in the industry are concentrated in areas such as AI computing power, AIOT, semiconductor equipment, key components, and rising storage prices [1] - The Guotai Science and Technology Chip ETF (589100) tracks the Science and Technology Chip Index (000685), which saw a daily fluctuation of 20%. This index selects listed companies from the Science and Technology Innovation Board that are involved in the entire chip industry chain, covering upstream materials and equipment, midstream design and manufacturing, and downstream packaging and testing, reflecting the overall performance of China's chip industry in technological innovation and high-end manufacturing [1]

Group 1 - The AI industry chain is experiencing a positive trend, with strong downstream demand and short-term supply challenges in infrastructure, particularly regarding power and resource shortages [1] - There are significant investment opportunities in power supply and resources due to these shortages, and domestic computing power has substantial growth potential [1] - With improved liquidity expectations and risk appetite, the technology sector is likely to benefit the most, with the ChiNext board expected to lead the recovery [1] Group 2 - The Guotai 50 ETF (159375) tracks the ChiNext 50 Index (399673), which has a daily fluctuation of up to 20%, reflecting the performance of 50 high-liquidity stocks in the ChiNext market [1] - The index components are primarily from high-growth sectors such as power equipment and biomedicine, showcasing a combination of technological innovation and sustained growth potential [1]